Lin Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin Zhou has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Shaohua Wei
College of Chemistry and Materials Science
30 shared publications Shaohua Wei
College of Chemistry and Materials Science Jiangsu Key Laboratory of Bio‐functional Materials Jiangsu Collaborative Innovation Centre of Biomedical Functional Materials Nanjing Normal University Nanjing China
17 shared publications- Jiahong Zhou
Nanjing Normal University
10 shared publications Jiahong Zhou
College of Chemistry and Materials Science
9 shared publications- Jian Shen
Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Jiangsu Key Laboratory of Bio-functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, PR China
9 shared publications Chongchong Wang
School of Chemistry and Chemical Engineering Yancheng Institute of Technology Yancheng 224051 China
7 shared publications
Latest Publications
- 17 November 2026
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 55 (44) , 15722-15738
Establishment of urinary hydrogen peroxide as an early indicator for AKI monitoring and its electrochemical detection
A CuO/ZnPc-Cu modified screen-printed sensor enables non-invasive electrochemical detection of urinary H 2 O 2 , achieving early acute kidney injury (AKI) diagnosis 3 h prior to traditional clinical indicators.
- 17 November 2026
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 55 (44) , 15722-15738
Establishment of urinary hydrogen peroxide as an early indicator for AKI monitoring and its electrochemical detection
A CuO/ZnPc-Cu modified screen-printed sensor enables non-invasive electrochemical detection of urinary H 2 O 2 , achieving early acute kidney injury (AKI) diagnosis 3 h prior to traditional clinical indicators.
- Open Access
- 23 September 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (37) , e74609
Facile Synthesis of Cu(OH) 2 Rods Supported on Activated Carbon as Efficient Catalyst for Nitrophenol Reduction
Aromatic amines constitute pivotal structural motifs in fine chemicals and environmental remediation, necessitating efficient catalysts for nitroarene reduction. Inspired by commercial Pd/C, we devised a facile one‐step protocol to in‐situ grow needle‐like Cu(OH) 2 nanocrystals on activated carbon, affording Cu(OH) 2 @AC composites. Systematic XRD, XPS, and TEM characterizations elucidated their phase composition and microstructure. In aqueous NaBH 4 ‐mediated reductions, the optimal Cu(OH) 2 @AC‐3 delivered activity rivaling commercial Pd/C while outperforming numerous reported non‐noble‐metal catalysts for the reduction of p‐nitrophenol (particularly 4‐nitrophenol), and showed the potential to be extended to a broader scope of nitroarene reductions. The catalyst retained robust performance over ten consecutive cycles with negligible copper leaching (0.07%), evidencing strong interfacial metal‐support interaction. Kinetic analysis confirmed that the reduction followed pseudo‐first‐order kinetics, and the apparent rate constant k was determined accordingly. The catalyst integrates facile preparation, earth‐abundant raw materials, and low cost, coupled with excellent scalability for large‐scale production, holding substantial promise for applications in wastewater remediation and fine chemical synthesis.
- 23 September 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (37) , e74609
Open AccessFacile Synthesis of Cu(OH) 2 Rods Supported on Activated Carbon as Efficient Catalyst for Nitrophenol Reduction
Aromatic amines constitute pivotal structural motifs in fine chemicals and environmental remediation, necessitating efficient catalysts for nitroarene reduction. Inspired by commercial Pd/C, we devised a facile one‐step protocol to in‐situ grow needle‐like Cu(OH) 2 nanocrystals on activated carbon, affording Cu(OH) 2 @AC composites. Systematic XRD, XPS, and TEM characterizations elucidated their phase composition and microstructure. In aqueous NaBH 4 ‐mediated reductions, the optimal Cu(OH) 2 @AC‐3 delivered activity rivaling commercial Pd/C while outperforming numerous reported non‐noble‐metal catalysts for the reduction of p‐nitrophenol (particularly 4‐nitrophenol), and showed the potential to be extended to a broader scope of nitroarene reductions. The catalyst retained robust performance over ten consecutive cycles with negligible copper leaching (0.07%), evidencing strong interfacial metal‐support interaction. Kinetic analysis confirmed that the reduction followed pseudo‐first‐order kinetics, and the apparent rate constant k was determined accordingly. The catalyst integrates facile preparation, earth‐abundant raw materials, and low cost, coupled with excellent scalability for large‐scale production, holding substantial promise for applications in wastewater remediation and fine chemical synthesis.
- Open Access
- 19 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (62)
Modification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation
Succinate dehydrogenase (SDH, complex II) connects the tricarboxylic acid (TCA) cycle to the electron transport chain (ETC), maintaining mitochondrial energy homeostasis. Selective SDH inhibition in diseased tissue has remained challenging due to the highly conserved catalytic architecture across normal tissues. Here, we reveal that SDH catalytic activity depends on the acetylation state of its catalytic subunit A (SDHA): the non‐acetylated form is catalytically active but exhibits fragile homeostasis in bladder cancer, contrasting with its robust maintenance in normal cells. Guided by this insight, we designed ZPI‐3, a conformationally optimized inhibitor that selectively engages the non‐acetylated SDHA, suppressing tumor SDH activity and growth while sparing normal cells. In orthotopic NMIBC models, ZPI‐3 outperforms mitomycin‐C. Differential SDH responses to ZPI‐3 in clinical specimens further suggest its potential for patient stratification and precision therapy. These findings establish modification‐selective inhibition as a paradigm for tumor‐selective mitochondrial modulation.
- 19 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (62)
Open AccessModification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation
Succinate dehydrogenase (SDH, complex II) connects the tricarboxylic acid (TCA) cycle to the electron transport chain (ETC), maintaining mitochondrial energy homeostasis. Selective SDH inhibition in diseased tissue has remained challenging due to the highly conserved catalytic architecture across normal tissues. Here, we reveal that SDH catalytic activity depends on the acetylation state of its catalytic subunit A (SDHA): the non‐acetylated form is catalytically active but exhibits fragile homeostasis in bladder cancer, contrasting with its robust maintenance in normal cells. Guided by this insight, we designed ZPI‐3, a conformationally optimized inhibitor that selectively engages the non‐acetylated SDHA, suppressing tumor SDH activity and growth while sparing normal cells. In orthotopic NMIBC models, ZPI‐3 outperforms mitomycin‐C. Differential SDH responses to ZPI‐3 in clinical specimens further suggest its potential for patient stratification and precision therapy. These findings establish modification‐selective inhibition as a paradigm for tumor‐selective mitochondrial modulation.
- 25 June 2026
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 25 (7) , 1291-1306
The linker governs the organelle targeting of TPP⁺-modified zinc phthalocyanine photosensitizers
Mitochondria are key targets in anticancer drug design owing to their central roles in cancer cell apoptosis and energy metabolism. In this study, we design and synthesize two triphenylphosphonium (TPP⁺)-modified zinc phthalocyanine (ZnPc) photosensitizers: ZnPc-O3-P(ph)3 linked by a polyethylene glycol (PEG) chain and ZnPc-C5-P(ph)3 linked by an alkyl chain. Subcellular localization studies show that ZnPc-O3-P(ph)3 precisely targets mitochondria, whereas ZnPc-C5-P(ph)3 unexpectedly accumulates in lysosomes. This finding overturns the conventional assumption that TPP⁺ confers universal mitochondrial targeting and reveals that linker structure critically governs TPP⁺-mediated subcellular localization. ZnPc-O3-P(ph)3 has a phototoxic index (PI, defined as the ratio of IC₅₀ in the dark to IC₅₀ under illumination) of 7.51 × 103, 544-fold higher than that of ZnPc-C5-P(ph)3 (PI = 13.8) and 10.4-fold higher than the clinical phthalocyanine photosensitizer photosens (PI = 725). In an orthotopic bladder cancer mouse model, ZnPc-O3-P(ph)3 exhibits therapeutic efficacy comparable to that of the first-line drug mitomycin C (MMC). This study demonstrates that linker design can dominate the subcellular fate of TPP⁺-conjugated agents, providing a new paradigm for targeted therapeutic development.
- 25 June 2026
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 25 (7) , 1291-1306
The linker governs the organelle targeting of TPP⁺-modified zinc phthalocyanine photosensitizers
Mitochondria are key targets in anticancer drug design owing to their central roles in cancer cell apoptosis and energy metabolism. In this study, we design and synthesize two triphenylphosphonium (TPP⁺)-modified zinc phthalocyanine (ZnPc) photosensitizers: ZnPc-O3-P(ph)3 linked by a polyethylene glycol (PEG) chain and ZnPc-C5-P(ph)3 linked by an alkyl chain. Subcellular localization studies show that ZnPc-O3-P(ph)3 precisely targets mitochondria, whereas ZnPc-C5-P(ph)3 unexpectedly accumulates in lysosomes. This finding overturns the conventional assumption that TPP⁺ confers universal mitochondrial targeting and reveals that linker structure critically governs TPP⁺-mediated subcellular localization. ZnPc-O3-P(ph)3 has a phototoxic index (PI, defined as the ratio of IC₅₀ in the dark to IC₅₀ under illumination) of 7.51 × 103, 544-fold higher than that of ZnPc-C5-P(ph)3 (PI = 13.8) and 10.4-fold higher than the clinical phthalocyanine photosensitizer photosens (PI = 725). In an orthotopic bladder cancer mouse model, ZnPc-O3-P(ph)3 exhibits therapeutic efficacy comparable to that of the first-line drug mitomycin C (MMC). This study demonstrates that linker design can dominate the subcellular fate of TPP⁺-conjugated agents, providing a new paradigm for targeted therapeutic development.
- 9 May 2026
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 139, 118701
Oleic acid modification enables lysosomal escape of phthalocyanine photosensitizer for effective bladder cancer treatment
- 9 May 2026
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 139, 118701
Oleic acid modification enables lysosomal escape of phthalocyanine photosensitizer for effective bladder cancer treatment
- 3 March 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 309, 118736
Light-activated targeted degradation of VHL drug for selective tumor killing: A novel strategy for precision therapy of bladder cancer
- 3 March 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 309, 118736
Light-activated targeted degradation of VHL drug for selective tumor killing: A novel strategy for precision therapy of bladder cancer
- 14 January 2026
- Published by Wiley in Chemnanomat
- Vol. 12 (1)
Phase‐Dependent Antitumor Activity of Manganese Sulfide Nanomaterials
Crystal polymorph engineering represents a pivotal strategy for enhancing the antitumor efficacy of pharmaceuticals. Current investigations on crystal engineering of antitumor agents are predominantly focused on organic small‐molecule drugs, whereas the correlation between crystal structure and bioactivity in inorganic nanomaterials remains underexplored. Herein, we report a comparative study on two crystalline polymorphs of manganese sulfide (MnS), α ‐MnS and γ ‐MnS, to unravel their distinct antitumor performances. Compared with γ ‐MnS, α ‐MnS demonstrates superior capacity in inducing intracellular reactive oxygen species (ROS) generation, leading to enhanced cytotoxicity against 4T1, A549, and MCF‐7 tumor cells. In a 4T1 tumor‐bearing mouse model, α ‐MnS treatment significantly reduces tumor volume relative to γ ‐MnS, while maintaining excellent biosafety profiles. These findings shed light on the structure–activity relationship of inorganic nanomaterials, providing a novel theoretical paradigm for the rational design of high‐performance nanotherapeutics with precise crystal form‐bioactivity matching.
- 14 January 2026
- Published by Wiley in Chemnanomat
- Vol. 12 (1)
Phase‐Dependent Antitumor Activity of Manganese Sulfide Nanomaterials
Crystal polymorph engineering represents a pivotal strategy for enhancing the antitumor efficacy of pharmaceuticals. Current investigations on crystal engineering of antitumor agents are predominantly focused on organic small‐molecule drugs, whereas the correlation between crystal structure and bioactivity in inorganic nanomaterials remains underexplored. Herein, we report a comparative study on two crystalline polymorphs of manganese sulfide (MnS), α ‐MnS and γ ‐MnS, to unravel their distinct antitumor performances. Compared with γ ‐MnS, α ‐MnS demonstrates superior capacity in inducing intracellular reactive oxygen species (ROS) generation, leading to enhanced cytotoxicity against 4T1, A549, and MCF‐7 tumor cells. In a 4T1 tumor‐bearing mouse model, α ‐MnS treatment significantly reduces tumor volume relative to γ ‐MnS, while maintaining excellent biosafety profiles. These findings shed light on the structure–activity relationship of inorganic nanomaterials, providing a novel theoretical paradigm for the rational design of high‐performance nanotherapeutics with precise crystal form‐bioactivity matching.
- 20 November 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 168, 109173
Electrochemical sensor for urinary H O detection to aid AKI diagnosis and treatment evaluation
- 20 November 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 168, 109173
Electrochemical sensor for urinary H O detection to aid AKI diagnosis and treatment evaluation
- 5 September 2025
- Published by Elsevier in Dyes and Pigments
- Vol. 245
From cell membrane to lysosome: Arginine modification boosts the phototoxic index of zinc phthalocyanine for efficient bladder cancer treatment
- 5 September 2025
- Published by Elsevier in Dyes and Pigments
- Vol. 245
From cell membrane to lysosome: Arginine modification boosts the phototoxic index of zinc phthalocyanine for efficient bladder cancer treatment
- 5 July 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 163, 108730
A mono-substituted aluminum phthalocyanine photosensitizer with high phototoxicity index for effective bladder cancer treatment
- 5 July 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 163, 108730
A mono-substituted aluminum phthalocyanine photosensitizer with high phototoxicity index for effective bladder cancer treatment